Study: Genentech's Cancer Fighter Avastin Helps Sickest Patients

A new study found cancer patients treated with a new drug survived two months longer than those treated only with chemotherapy. With FDA approval and more detailed research coming out, Avastin could become the next hot cancer-fighting medicine.

Uh oh–you've read all five of your free articles for this month.

Insider Online Only

$19.95/yr US PRICE


Technologies are revolutionizing how we work and how companies operate.

You've read of free articles this month.